TCM
ARRY

TimesSquare Capital Management’s Array Biopharma Inc ARRY Stock Holding History

TimesSquare Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,639,989
Closed -$16.6M – 258
2015
Q3 		$16.6M Sell
3,639,989
-145,106
-4% -$860K 0.1% 210
2015
Q2 		$27.3M Sell
3,785,095
-21,655
-0.6% -$160K 0.15% 197
2015
Q1 		$28.1M Sell
3,806,750
-285,700
-7% -$2.03M 0.15% 199
2014
Q4 		$19.4M Buy
4,092,450
+152,600
+4% +$604K 0.11% 209
2014
Q3 		$14.1M Buy
3,939,850
+65,900
+2% +$260K 0.08% 223
2014
Q2 		$17.7M Sell
3,873,950
-53,550
-1% -$221K 0.1% 214
2014
Q1 		$18.5M Sell
3,927,500
-61,700
-2% -$310K 0.1% 214
2013
Q4 		$20M Buy
3,989,200
+2,524,400
+172% +$13.7M 0.1% 209
2013
Q3 		$9.11M Buy
+1,464,800
New +$8.7M 0.05% 226

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return